Paper33910046
Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance.
Liu Y and 19 others. Cell Metab, 2021. Cited by 327 papers, by iCite.
Cite this record
ConductScience Library. Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Papers, record 33910046. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33910046
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Immunologic Surveillance | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Female | |
| Melanoma, Experimental | |
| Mice | |
| Mice, Inbred C57BL |
Source PubMed
Cited by242
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 327 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978979 | Mechanisms by which programmed cell death mediates immune evasion and antitumour immunity in oropharyngeal cancer. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42978979 | PubMed |
| 42975694 | Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/42975694 | PubMed |
| 42918854 | Molecular functions, cellular responses and pathological implications of the RNA modification N6-methyladenosine. | Nat Rev Mol Cell Biol | 2026 | https://conductscience.org/library/papers/42918854 | PubMed |
| 42864360 | In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion. | Nat Commun | 2026 | https://conductscience.org/library/papers/42864360 | PubMed |
| 42756925 | m6A-Targeted Cancer Therapy: Molecular Targets, Inhibitors, and Nanodelivery Strategies. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42756925 | PubMed |
| 42754163 | RNA Demethylase FTO Uses Conserved Aromatic Residues to Recognize the mRNA 5' Cap and Promote Efficient m6Am Demethylation. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42754163 | PubMed |
| 42729867 | Metabolic reprogramming and immune evasion interaction in the tumor microenvironment promote tumor progression. | Front Oncol | 2026 | https://conductscience.org/library/papers/42729867 | PubMed |
| 42693106 | Longer-lived mammals exhibit greater evolutionary conservatism and epigenetic modification at cancer-associated loci. | Nat Commun | 2026 | https://conductscience.org/library/papers/42693106 | PubMed |
| 42548706 | Reader-dependent functional duality of FTO: a context-switching node at the intersection of immune evasion and therapeutic resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548706 | PubMed |
| 42541138 | The role, regulatory mechanisms, and therapeutic implications of FTO in gastrointestinal cancer. | Genes Dis | 2026 | https://conductscience.org/library/papers/42541138 | PubMed |
| 42527031 | CXCR2-mediated metabolic interaction between prostate cancer cells and the immunosuppressive tumor microenvironment. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42527031 | PubMed |
| 42515673 | m1A and m6A RNA Methylations as Druggable Targets in Cancer. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515673 | PubMed |
| 42491192 | m6A RNA modification: a central epitranscriptomic switch orchestrating oncogenic signaling and glycolytic reprogramming in cancer. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42491192 | PubMed |
| 42488625 | RNA epitranscriptomic regulation of tumor immune evasion: mechanisms, context-dependent roles, and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42488625 | PubMed |
| 42445445 | Integrative bioinformatics and experimental analysis identify S100A10 as a diagnostic and prognostic biomarker in pancreatic adenocarcinoma. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42445445 | PubMed |
| 42435175 | Influence of RNA Modifications on Cancer Metabolism: Interplay with Hypoxia and Therapeutic Implications. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435175 | PubMed |
| 42426902 | Cancer stem cell plasticity: mechanisms, immune microenvironment crosstalk, and therapeutic implications. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42426902 | PubMed |
| 42397900 | A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC. | Sci Adv | 2026 | https://conductscience.org/library/papers/42397900 | PubMed |
| 42345006 | RNA Modifications in Tumor Microenvironment: A New Dimension for Cancer Treatment. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42345006 | PubMed |
| 42338603 | Glycolytic reprogramming in cancer: immune crosstalk, nutrient competition, and supportive care perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42338603 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CEBPB | 1051 | PubTator's text mining | https://conductscience.org/library/genes/1051 | NCBI Gene |
| FTO | 79068 | PubTator's text mining | https://conductscience.org/library/genes/79068 | NCBI Gene |
| GPM6A | 2823 | PubTator's text mining | https://conductscience.org/library/genes/2823 | NCBI Gene |
| JUN | 3725 | PubTator's text mining | https://conductscience.org/library/genes/3725 | NCBI Gene |
| JUNB | 3726 | PubTator's text mining | https://conductscience.org/library/genes/3726 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33910046
GET https://conductscience.org/api/papers/v1/33910046/cited_by?page=2